We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+28.76%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$12.4B
AUM Growth
+$2.29B
Cap. Flow
-$8.07M
Cap. Flow %
-0.07%
Top 10 Hldgs %
9.07%
Holding
848
New
74
Increased
361
Reduced
233
Closed
101
Avg Time Held
18.2 quarters
Top 10 Avg Time Held
3.2 quarters
Top 20 Avg Time Held
7.1 quarters

Top Buys

Rank Stock Value
1
MANH icon
Manhattan Associates
MANH
+$43.3M
2
MSA icon
Mine Safety
MSA
+$37.1M
3
YSWY icon
Yesway Inc
YSWY
+$34.7M
4
DORM icon
Dorman Products
DORM
+$24.6M
5
AVTR icon
Avantor
AVTR
+$19M

Top Sells

Rank Stock Value
1
COHU icon
Cohu
COHU
+$54.5M
2
CPRX icon
Catalyst Pharmaceutical
CPRX
+$51.1M
3
MKSI icon
MKS Inc
MKSI
+$44.5M
4
VSH icon
Vishay Intertechnology
VSH
+$40.2M
5
LFUS icon
Littelfuse
LFUS
+$35.4M

Sector Composition

Rank Sector Weight
1 Industrials 26.88%
2 Technology 19.45%
3 Financials 14.84%
4 Consumer Discretionary 12.86%
5 Healthcare 9.15%

No holdings matched the selected filter criteria.

Similar funds

Royce & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, Royce & Associates held 848 positions worth $12.4B, up 23% from $10.1B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Royce & Associates's Q2 2026 filing shows 74 new, 361 increased, 233 reduced and 101 closed positions. Its largest new stake was Manhattan Associates: 314,304 shares worth $43.8M. The largest sale was Cohu, an estimated $54.5M.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q2 2026 buy was Manhattan Associates: 314,304 shares worth $43.8M.
  • Royce & Associates added most to Mine Safety in Q2 2026, an estimated $37.1M increase.
  • Royce & Associates's biggest Q2 2026 reduction was Cohu, cutting an estimated $54.5M.
  • Royce & Associates fully exited Transmedics in Q2 2026, selling an estimated $24.3M.
  • Royce & Associates's ten largest holdings make up 9.1% of its $12.4B portfolio in Q2 2026.
  • Royce & Associates opened 74 new positions and closed 101 in Q2 2026.
  • Royce & Associates's portfolio value rose 23% quarter-over-quarter to $12.4B.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.